Stock Still Worth Buying: AMD's Rally and AI Outlook
After a strong rally, investors ask if AMD remains a smart bet. This in-depth look weighs AI roadmaps, growth drivers...
Which Retirement Index Fund Has The Best Fee
Find which retirement index fund has the best fee and how this impacts your overall returns. Learn to spot the true cost leaders.
28,127 articles
Data Center Hate Snowballing Pushes 2026 Construction Delays Higher
A new watchdog report shows the first quarter of 2026 saw construction setbacks for data centers surge past 2025 leve...
What Affordability Crisis? Rich Fuel Housing Rally So Far
We examine how wealthy buyers are sustaining housing activity even as the broader market cools for most households. T...
Health Care Been Propping Up Jobs Market Falters Now
February delivered the first drop in health care payrolls in more than four years, signaling a shift in a market that...
President Trump Went Palantir: Should You Buy Now?
Palantir shares moved higher as market chatter tied the AI and national security agenda to politics. Investors weigh ...
Crypto News: Bitcoin Pressure Rises as STRC Peg Fails
Bitcoin anchors a high-stakes test as the STRC peg breaks and liquidity tightens. Microsoft issues a security advisor...
Bezos Raising Billion Rocket Financing Sends Market Signal
Jeff Bezos-led Blue Origin plans a $10 billion external round at a $130 billion valuation, a move that reframes priva...
Oracle's AI-Fueled Growth Silences Doubters — for Now
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
Workhorse (WKHS) 2026 Earnings Outlook and Analysis
An in-depth look at Workhorse's path in 2026, focusing on earnings potential, drivers, and strategies for investors n...
Is This Defense Stock Still a Smart Buy After Its Rally?
Investors often chase the 'smartest' stock, but in defense, the best move is a disciplined plan. This article breaks ...
Cramer: Hynix Last 2026 IPO Window Narrows After SK Hynix Debut
SK Hynix closed the largest foreign U.S. listing on record, raising $26.5 billion. Analysts question whether the 2026...
Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status